These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10325717)

  • 21. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.
    Hitchcock WP
    Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bordetella pertussis in a neonatal intensive care unit: identification of the mother as the likely source.
    Elumogo TN; Booth D; Enoch DA; Kuppuswamy A; Tremlett C; Williams CJ; Shankar A; Morter S
    J Hosp Infect; 2012 Oct; 82(2):133-5. PubMed ID: 22940441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009.
    Jardine A; Conaty SJ; Lowbridge C; Thomas J; Staff M; Vally H
    Commun Dis Intell Q Rep; 2010 Jun; 34(2):116-21. PubMed ID: 20677421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination.
    Orenstein WA
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S147-50. PubMed ID: 10447034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis.
    Dodhia H; Crowcroft NS; Bramley JC; Miller E
    J Public Health Med; 2002 Sep; 24(3):200-6. PubMed ID: 12831090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
    de Greeff SC; de Melker HE; Westerhof A; Schellekens JF; Mooi FR; van Boven M
    Epidemiology; 2012 Nov; 23(6):852-60. PubMed ID: 23018969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
    Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acellular pertussis vaccine (Pa)].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):325-9. PubMed ID: 7491431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal pertussis, cocooning and maternal immunization.
    Swamy GK; Wheeler SM
    Expert Rev Vaccines; 2014 Sep; 13(9):1107-14. PubMed ID: 25075629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection.
    Healy CM; Rench MA; Wootton SH; Castagnini LA
    Pediatr Infect Dis J; 2015 Jan; 34(1):22-6. PubMed ID: 24992123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of vaccination coverage on pertussis transmission in France.
    Grimprel E; Baron S; Lévy-Bruhl D; Garnier JM; N'jamkepo E; Guiso N; Bégué P
    Lancet; 1999 Nov; 354(9191):1699-700. PubMed ID: 10568576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keeping vulnerable children safe from pertussis: preventing nosocomial pertussis transmission in the neonatal intensive care unit.
    Greer AL; Fisman DN
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1084-9. PubMed ID: 19785517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Whooping cough is a risk to infants. The disease is circulating among adolescents and adults].
    Nilsson L; Von Segebaden K; Blennow M; Linde A; Uhnoo I
    Lakartidningen; 2013 Sep 11-17; 110(37):1599-602. PubMed ID: 24163932
    [No Abstract]   [Full Text] [Related]  

  • 34. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.
    Coudeville L; van Rie A; Andre P
    Epidemiol Infect; 2008 May; 136(5):604-20. PubMed ID: 17612417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pertussis--a life-threatening infection in infants. Is there a need for booster vaccination?].
    Pedersen T
    Ugeskr Laeger; 2008 Apr; 170(17):1474. PubMed ID: 18462631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of the serial interval of pertussis in Dutch households.
    Te Beest DE; Henderson D; van der Maas NA; de Greeff SC; Wallinga J; Mooi FR; van Boven M
    Epidemics; 2014 Jun; 7():1-6. PubMed ID: 24928663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pertussis in infants and the resurgence of a vaccine preventable disease: what to do? Commentary.
    Fedele G; Stefanelli P
    Ann Ist Super Sanita; 2017; 53(2):100-103. PubMed ID: 28617254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.